Introduction: Oxytocin has long been used for the induction of labor, but it can be associated with fetal and maternal complications that could potentially be reduced by discontinuing the treatment during labor. We performed this meta-analysis to determine whether discontinuation of oxytocin, once the active phase of induced labor is achieved, affects the second stage of labor and the rate of various maternal and fetal outcomes. Methods: We searched for randomized controlled trials (RCTs) comparing discontinuing oxytocin after the active stage of labor is established versus continuing to give oxytocin throughout the labor process using databases like PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov from the inception till February 1, 2025. Results were pooled using RevMan 5.4, and the effect metric was the risk ratio (RR). Our systematic review and meta-analysis was registered with PROSPERO (CRD42024534076). Results: Pooled analysis of fifteen RCTs included in our review showed that discontinuation of oxytocin, once the active stage of labor is established, did not reduce the primary outcome of incidence of cesarean delivery (RR = 0.91; 95% CI, 0.77–1.07; p = 0.21). The incidence of uterine tachysystole, postpartum hemorrhage, and non-reassuring fetal heart rate was significantly lower in the oxytocin discontinuation group compared to oxytocin continuation. The rates of uterine rupture, vaginal instrument use, epidural use, and neonatal intensive care unit admission did not differ among both groups. The duration of the active stage of labor was significantly prolonged in the oxytocin-discontinued group; however, the duration of the second stage of labor and total delivery time remained comparable between the two groups. Conclusions: Discontinuation of oxytocin during the active phase of labor did not reduce the incidence of cesarean section or neonatal morbidity. We therefore recommend an individualized approach regarding oxytocin discontinuation while factoring in patient-specific factors. New large-scale RCTs focusing on identifying subgroups that might benefit from one approach over the other are required to provide more reliable results.

1.
Martin
JA
,
Hamilton
BE
,
Osterman
MJK
,
Driscoll
AK
.
Births: final data for 2018
.
Natl Vital Stat Rep
.
2019
;
68
(
13
):
1
47
.
2.
Daly
D
,
Minnie
KCS
,
Blignaut
A
,
Blix
E
,
Vika Nilsen
AB
,
Dencker
A
, et al
.
How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries
.
PLoS One
.
2020
;
15
(
7
):
e0227941
.
3.
El-Hakem
MMA
,
Hassan
FI
,
Taha
S
.
Continuation versus discontinuation of oxytocin infusion throughout the active phase of labor and its effect on the course of induced labor
.
4.
Osilla
EV
,
Patel
P
,
Sharma
S
.
Oxytocin
.
StatPearls
.
StatPearls Publishing
;
2025
. http://www.ncbi.nlm.nih.gov/books/NBK507848/ (accessed April 21, 2025).
5.
Mussi
S
,
Incerti
M
,
Plevani
C
,
Ghidini
A
,
Pezzullo
JC
,
Locatelli
A
.
Effect of oxytocin during labor on neonatal acidemia
.
J Matern Fetal Neonatal Med
.
2016
;
29
(
19
):
3098
103
.
6.
Girault
A
,
Sentilhes
L
,
Desbrière
R
,
Berveiller
P
,
Korb
D
,
Bertholdt
C
, et al
.
Impact of discontinuing oxytocin in active labour on neonatal morbidity: an open-label, multicentre, randomised trial
.
Lancet
.
2023
;
402
(
10417
):
2091
100
.
7.
Simpson
KR
,
James
DC
.
Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns
.
Am J Obstet Gynecol
.
2008
;
199
(
1
):
34.e1
345
.
8.
Bor
P
,
Ledertoug
S
,
Boie
S
,
Knoblauch
N
,
Stornes
I
.
Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial
.
BJOG Int J Obstet Gynaecol
.
2016
;
123
(
1
):
129
35
.
9.
Phaneuf
S
,
Asbóth
G
,
Carrasco
MP
,
Europe-Finner
GN
,
Saji
F
,
Kimura
T
, et al
.
The desensitization of oxytocin receptors in human myometrial cells is accompanied by down-regulation of oxytocin receptor messenger RNA
.
J Endocrinol
.
1997
;
154
(
1
):
7
18
.
10.
Diven
LC
,
Rochon
ML
,
Gogle
J
,
Eid
S
,
Smulian
JC
,
Quiñones
JN
.
Oxytocin discontinuation during active labor in women who undergo labor induction
.
Am J Obstet Gynecol
.
2012
;
207
(
6
):
471.e1
8
.
11.
Chookijkul
L
,
Prommas
S
,
Pariyawateekul
P
,
Orungrote
N
,
Smanchat
B
,
Suwannarurk
K
.
Cesarean section rate in oxytocin infusion between continuous until delivery and discontinuation at active phase of labor: a randomized controlled study
.
2016
;
24
(
2
).
12.
Page
MJ
,
McKenzie
JE
,
Bossuyt
PM
,
Boutron
I
,
Hoffmann
TC
,
Mulrow
CD
, et al
.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
.
BMJ
.
2021
;
372
:
n71
.
13.
Higgins
JP
.
Cochrane handbook for systematic reviews of interventions version 5.0. 1
.
The Cochrane Collaboration
;
2008
. Published online Available from: https://www.Cochrane-Handb.Org
14.
Sterne
JAC
,
Savović
J
,
Page
MJ
,
Elbers
RG
,
Blencowe
NS
,
Boutron
I
, et al
.
RoB 2: a revised tool for assessing risk of bias in randomised trials
.
BMJ
.
2019
;
366
:
l4898
.
15.
Bahadoran
P
,
Falahati
J
,
Shahshahan
Z
,
Kianpour
M
.
The comparative examination of the effect of two oxytocin administration methods of labor induction on labor duration stages
.
Iran J Nurs Midwifery Res
.
2011
;
16
(
1
):
100
5
.
16.
Begum
LN
,
Sultana
M
,
Nahar
S
,
Begum
R
,
Barua
S
.
A randomized clinical trial on the need of continuing oxytocin infusion in active phase of induced labour
.
Chattagram Maa-O-Shishu Hosp Med Coll J
.
2013
;
12
(
2
):
23
30
.
17.
Boie
S
,
Glavind
J
,
Uldbjerg
N
,
Steer
PJ
,
Bor
P
,
CONDISOX trial group
.
Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial
.
BMJ
.
2021
;
373
:
n716
.
18.
Daniel-Spiegel
E
,
Weiner
Z
,
Ben-Shlomo
I
,
Shalev
E
.
For how long should oxytocin be continued during induction of labour
.
BJOG Int J Obstet Gynaecol
.
2004
;
111
(
4
):
331
4
.
19.
Chopra
S
,
SenGupta
S
,
Jain
V
,
Kumar
P
.
Stopping oxytocin in active labor rather than continuing it until delivery: a viable option for the induction of labor
.
Oman Med J
.
2015
;
30
(
5
):
320
5
.
20.
Ustunyurt
E
,
Ugur
M
,
Ustunyurt
BO
,
Iskender
TC
,
Ozkan
O
,
Mollamahmutoglu
L
.
Prospective randomized study of oxytocin discontinuation after the active stage of labor is established
.
J Obstet Gynaecol Res
.
2007
;
33
(
6
):
799
803
.
21.
Öztürk
FH
,
Yılmaz
SS
,
Yalvac
S
,
Kandemir
Ö
.
Effect of oxytocin discontinuation during the active phase of labor
.
J Matern Fetal Neonatal Med
.
2015
;
28
(
2
):
196
8
.
22.
Mitra
M
,
Sengupta
M
,
Ghosal
R
,
Saha
C
,
Bandhya
D
,
Ghosh
D
.
Continuation versus Discontinuation of Oxytocin in Active Phase of Labour- A Randomised Trial
.
J Evolution Med Dental Sci
.
2019
;
8
(
44
). https://scholar.google.com/scholar?q=Continuation+versus+discontinuation+of+oxytocin+in+active+phase+of+labour-+a+randomised+trial+Mitra+2019.
23.
Vlachos
DEG
,
Pergialiotis
V
,
Papantoniou
N
,
Trompoukis
S
,
Vlachos
GD
.
Oxytocin discontinuation after the active phase of labor is established
.
J Matern Fetal Neonatal Med
.
2015
;
28
(
12
):
1421
7
.
24.
Saccone
G
,
Ciardulli
A
,
Baxter
JK
,
Quiñones
JN
,
Diven
LC
,
Pinar
B
, et al
.
Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis
.
Obstet Gynecol
.
2017
;
130
(
5
):
1090
6
.
25.
Jiang
D
,
Yang
Y
,
Zhang
X
,
Nie
X
.
Continued versus discontinued oxytocin after the active phase of labor: an updated systematic review and meta-analysis
.
PLoS One
.
2022
;
17
(
5
):
e0267461
.
26.
Hernández-Martínez
A
,
Arias-Arias
A
,
Morandeira-Rivas
A
,
Pascual-Pedreño
AI
,
Ortiz-Molina
EJ
,
Rodriguez-Almagro
J
.
Oxytocin discontinuation after the active phase of induced labor: a systematic review
.
Women Birth
.
2019
;
32
(
2
):
112
8
.
27.
Boie
S
,
Glavind
J
,
Velu
AV
,
Mol
BWJ
,
Uldbjerg
N
,
de Graaf
I
, et al
.
Discontinuation of intravenous oxytocin in the active phase of induced labour
.
Cochrane Database Syst Rev
.
2018
;
8
(
8
):
CD012274
.
28.
Seitchik
J
,
Castillo
M
.
Oxytocin augmentation of dysfunctional labor. III. Multiparous patients
.
Am J Obstet Gynecol
.
1983
;
145
(
7
):
777
80
.
29.
Dawood
MY
.
Novel approach to oxytocin induction-augmentation of labor. Application of oxytocin physiology during pregnancy
.
Adv Exp Med Biol
.
1995
;
395
:
585
94
.
30.
Selin
L
,
Almström
E
,
Wallin
G
,
Berg
M
.
Use and abuse of oxytocin for augmentation of labor
.
Acta Obstet Gynecol Scand
.
2009
;
88
(
12
):
1352
7
.
31.
Cahill
AG
,
Waterman
BM
,
Stamilio
DM
,
Odibo
AO
,
Allsworth
JE
,
Evanoff
B
, et al
.
Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery
.
Am J Obstet Gynecol
.
2008
;
199
(
1
):
32.e1
325
.
32.
Grotegut
CA
,
Paglia
MJ
,
Johnson
LNC
,
Thames
B
,
James
AH
.
Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony
.
Am J Obstet Gynecol
.
2011
;
204
(
1
):
56.e1
566
.
33.
Raghuraman
N
.
Role of oxytocin in the second stage of labor: a randomized controlled trial (the ROSSoL trial)
.
clinicaltrials.gov
;
2024
. https://clinicaltrials.gov/study/NCT04303702 (accessed January 1, 2024).
You do not currently have access to this content.